March 2024, Self-screen and Fujirebio Europe launch PreCursor-M AnoGYN assay (RUO) for methylation testing in anal specimens
Self-screen and Fujirebio Europe today announce an expansion of their commercial collaboration with the distribution of the PreCursor-M AnoGYN methylation-specific molecular assay from Self-screen B.V. The test is intended for the detection of promoter hypermethylation of the genes ASCL1 and ZNF582 and is used to test the methylations status of anal specimens for research use only (RUO). It complements Fujirebio’s HPV-associated molecular test portfolio.
